NAMENDA Side Effects

7021564-8 | Blood Pressure Increased, Depression, Hallucination, Somnolence, Syncope
on Sep 21, 2010 Female patient from UNITED STATES , 92 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, depression (What is depression?), hallucination, somnolence, syncope. Namenda dosage: Oral, 20 Mg (10 Mg, 2 In 1 D), Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

7017554-1 | Hepatotoxicity, Renal Failure Acute
Patient was taking Namenda (View Usage). Patient had the following side effects: hepatotoxicity, renal failure acute on Jul 26, 2010 from UNITED STATES Additional patient health information: Male patient , 83 years of age, was diagnosed with dementia alzheimer's type, hypertension, transient ischaemic attack and. Namenda dosage: . During the same period patient was treated with HYZAAR (View Hyzaar Review and Hyzaar Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), NIACIN (View Niacin Review and Niacin Label ), ARICEPT (View Aricept Review and Aricept Label ), AGGRENOX (View Aggrenox Review and Aggrenox Label ). Patient was hospitalized.

7017553-X | Hepatotoxicity, Renal Failure Acute
Adverse event was reported on Jul 23, 2010 by a Male patient taking Namenda (View Usage) (Dosage: ) was diagnosed with dementia alzheimer's type, hypertension, transient ischaemic attack and. Location: UNITED STATES , 83 years of age, After Namenda was administered, patient had the following side effects: hepatotoxicity, renal failure acute. During the same period patient was treated with HYZAAR (View Hyzaar Review and Hyzaar Label ), SPIRONOLACTONE TABLETS, USP (View Spironolactone Tablets, Usp Review and Spironolactone Tablets, Usp Label ), NIACIN (View Niacin Review and Niacin Label ), ARICEPT (View Aricept Review and Aricept Label ), AGGRENOX (View Aggrenox Review and Aggrenox Label ). Patient was hospitalized.

6971481-4 | Brain Oedema, Somnolence
on Sep 01, 2010 Male patient from UNITED STATES , 81 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: brain oedema, somnolence. Namenda dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), KLOR CON (View Klor-con Review and Klor-con Label ), QVAR 40 (View Qvar 40 Review and Qvar 40 Label ), NORVASC (View Norvasc Review and Norvasc Label ), SINGULAIR (View Singulair Review and Singulair Label ), HYTRIN (View Hytrin Review and Hytrin Label ).


6927421-7 | Blood Pressure Increased, Hallucination, Visual, Somnolence, Syncope
on Aug 09, 2010 Female patient from UNITED STATES , 92 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient had the following side effects: blood pressure increased, hallucination, visual, somnolence, syncope. Namenda dosage: Oral, 20 Mg (10 Mg, 2 In 1 D), Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

6877017-0 | Aggression, Asocial Behaviour, Condition Aggravated, Confusional State, Crying, Dementia Alzheimer's Type, Hypophagia
Patient was taking Namenda (View Usage). After Namenda was administered, patient had the following side effects: aggression, asocial behaviour, condition aggravated, confusional state, crying, dementia alzheimer's type, hypophagia on Jul 27, 2010 from UNITED STATES Additional patient health information: Female patient , 90 years of age, weighting 165.0 lb, was diagnosed with dementia alzheimer's type and. Namenda dosage: 5 Mg Daily Po.

6875661-8 | Agitation, Anxiety
Adverse event was reported on Jul 15, 2008 by a Female patient taking Namenda (View Usage) (Dosage: 7.5 Mg (7.5 Mg, Once A Day), Oral) was diagnosed with attention deficit/hyperactivity disorder, bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , 13 years of age, Patient experienced the following unwanted or unexpected effects: agitation, anxiety (What is anxiety?). During the same period patient was treated with LAMICTAL (160 Mg (160 Mg, Once A Day), Oral) (View Lamictal Review and Lamictal Label ).

6875660-6 | Blood Alkaline Phosphatase Increased
on May 09, 2008 Female patient from UNITED STATES , 65 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient had the following side effects: blood alkaline phosphatase increased. Namenda dosage: Oral. During the same period patient was treated with EXELON (RIVASTIGMINE TARTRATE) (RIVASTIGMINE TARTRATE) (View Exelon (rivastigmine Tartrate) (rivastigmine Tartrate) Review and Exelon (rivastigmine Tartrate) (rivastigmine Tartrate) Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ).

6875551-0 | Convulsion, Hypersomnia, Pain In Extremity
on May 06, 2008 Female patient from UNITED STATES , 90 years of age, weighting 119.0 lb, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: convulsion, hypersomnia, pain in extremity. Namenda dosage: 5 Mg (5 Mg, Oncea A Day), Oral; 10 Mg (5 Mg, Twice A Day), Oral; 15 Mg 915 Mg, Once A Day), Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), PROAMATINE (MIDODRINE HYDROCHLORIDE) (MIDODRINE HYDROCHLORIDE) (View Proamatine (midodrine Hydrochloride) (midodrine Hydrochloride) Review and Proamatine (midodrine Hydrochloride) (midodrine Hydrochloride) Label ). Patient was hospitalized.

6875540-6 | Orthostatic Hypotension
Patient was taking Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: orthostatic hypotension on May 13, 2008 from UNITED STATES Additional patient health information: Male patient , 82 years of age, was diagnosed with vascular dementia and. Namenda dosage: 20 Mg (10 Mg, Twice A Day), Oral; 10 Mg (5 Mg, Twice A Day), Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), SINEMET (View Sinemet Review and Sinemet Label ), LOVENOX (HEPARIN FRACTION, SODIUM SALT) (HEPARIN FRACTION, SODIUM SALT (View Lovenox (heparin-fraction, Sodium Salt) (heparin-fraction, Sodium Salt Review and Lovenox (heparin-fraction, Sodium Salt) (heparin-fraction, Sodium Salt Label ), ZESTRIL (View Zestril Review and Zestril Label ), COLACE (DOCUSATE SODIUM) (DOCUSATE SODIUM) (View Colace (docusate Sodium) (docusate Sodium) Review and Colace (docusate Sodium) (docusate Sodium) Label ), IRON (IRON) (IRON) (View Iron (iron) (iron) Review and Iron (iron) (iron) Label ), DUONEB (ALBUTEROL AND IPRATROPIUM) (View Duoneb (albuterol And Ipratropium) Review and Duoneb (albuterol And Ipratropium) Label ).

6875379-1 | Irritability, Nausea, Nervousness, Paranoia, Suicidal Ideation, Weight Increased
Adverse event was reported on May 02, 2008 by a Female patient taking Namenda (View Usage) (Dosage: 5 Mg (5 Mg, Once A Day), Oral; 10 Mg (5 Mg, Twice A Day), Oral; 15 Mg (15 Mg, Once A Day), Oral) was diagnosed with amnesia and. Location: UNITED STATES , 49 years of age, Patient had the following side effects: irritability, nausea (What is nausea?), nervousness, paranoia, suicidal ideation, weight increased. During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), ATIVAN (View Ativan Review and Ativan Label ).

6875289-X | Pneumonia, Urinary Tract Infection
on Jan 17, 2008 Male patient from UNITED STATES , 85 years of age, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?). Namenda dosage: 10 Mg (5 Mg, Twice A Day), Oral; 15 Mg (15 Mg, Once A Day), Oral; 5 Mg (5 Mg, Once A Day), Oral. During the same period patient was treated with SEROQUEL (QUETIAPINE FUMARATE) (QUETIAPINE FUMARATE) (View Seroquel (quetiapine Fumarate) (quetiapine Fumarate) Review and Seroquel (quetiapine Fumarate) (quetiapine Fumarate) Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), FLAXSEED OIL (FLAXSEED OIL) (FLAXSEED OIL) (View Flaxseed Oil (flaxseed Oil) (flaxseed Oil) Review and Flaxseed Oil (flaxseed Oil) (flaxseed Oil) Label ). Patient was hospitalized.

6875116-0 | Fall, Transient Ischaemic Attack, Urinary Incontinence
on Nov 15, 2007 Male patient from UNITED STATES , 69 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), transient ischaemic attack, urinary incontinence (What is urinary incontinence?). Namenda dosage: 20 Mg (20 Mg,once A Day),oral. During the same period patient was treated with RAZADYNE ER (GALANTAMINE ER) (View Razadyne Er (galantamine Er) Review and Razadyne Er (galantamine Er) Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ). Patient was hospitalized.

6875076-2 | Convulsion
Patient was taking Namenda (View Usage). Patient had the following side effects: convulsion on Oct 22, 2007 from UNITED STATES Additional patient health information: Female patient , 79 years of age, was diagnosed with dementia (What is dementia?) and. Namenda dosage: See Image. During the same period patient was treated with ARICEPT (10 Mg (10 Mg,once A Day)) (View Aricept Review and Aricept Label ), BENICAR (View Benicar Review and Benicar Label ), BONIVA (View Boniva Review and Boniva Label ), COREG (CARVEDILOL) (CARVDILOL) (View Coreg (carvedilol) (carvdilol) Review and Coreg (carvedilol) (carvdilol) Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ). Patient was hospitalized.

6875074-9 | Confusional State, Depression, Suicidal Ideation
Adverse event was reported on Oct 15, 2008 by a Male patient taking Namenda (View Usage) (Dosage: 5 Mg (5 Mg,1 In 1 D),oral) was diagnosed with amnesia and. Location: UNITED STATES , 82 years of age, After Namenda was administered, patient had the following side effects: confusional state, depression (What is depression?), suicidal ideation. During the same period patient was treated with ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), PROPAFENONE (View Propafenone Review and Propafenone Label ), IRON (View Iron Review and Iron Label ).

6875071-3 | Convulsion
on Oct 03, 2008 Female patient from UNITED STATES , 85 years of age, was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Namenda dosage: .

6875050-6 | Suicidal Ideation
on Sep 29, 2008 Female patient from UNITED STATES , 63 years of age, was diagnosed with migraine (What is migraine?) and was treated with Namenda (View Usage). Patient had the following side effects: suicidal ideation. Namenda dosage: 5 Mg (1 In 1 D),oral ; 10 Mg (5 Mg,2 In 1 D),oral. During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ), IMITREX (View Imitrex Review and Imitrex Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), CAFERGOT (View Cafergot Review and Cafergot Label ).

6875048-8 | Diverticulitis
Patient was taking Namenda (View Usage). After Namenda was administered, patient had the following side effects: diverticulitis on Jul 29, 2008 from UNITED STATES Additional patient health information: Female patient , 83 years of age, was diagnosed with dementia alzheimer's type and. Namenda dosage: 5 Mg (5 Mg,1 In 1 D),oral. During the same period patient was treated with INDERAL (View Inderal Review and Inderal Label ), ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized.

6875035-X | Accidental Overdose, Somnolence
Adverse event was reported on Jan 31, 2008 by a Female patient taking Namenda (View Usage) (Dosage: Oral ; 5 Mg (5 Mg,once A Day),oral) was diagnosed with dementia (What is dementia?) and. Location: UNITED STATES , 80 years of age, Patient experienced the following unwanted or unexpected effects: accidental overdose, somnolence. During the same period patient was treated with ARICEPT (10 Mg (10 Mg,once) ; Oral) (View Aricept Review and Aricept Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6875018-X | Cardiac Arrest
on Jan 15, 2008 Female patient from UNITED STATES , 86 years of age, weighting 175.0 lb, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?). Namenda dosage: 5 Mg (5 Mg,once A Day),oral. During the same period patient was treated with CELEXA (View Celexa Review and Celexa Label ), ZYPREXA ZYDIS (View Zyprexa Zydis Review and Zyprexa Zydis Label ). Patient was hospitalized.

6875001-4 | Bradycardia, Hypotension
on Sep 04, 2009 Female patient from UNITED STATES , 78 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: bradycardia, hypotension. Namenda dosage: 20 Mg (10 Mg,2 In 1 D),oral. During the same period patient was treated with ARICEPT (10 Mg (10 Mg,1 In 1 D),oral) (View Aricept Review and Aricept Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), REMERON (View Remeron Review and Remeron Label ), ELDERTONIC (View Eldertonic Review and Eldertonic Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6874998-6 | Convulsion
Patient was taking Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion on Jul 22, 2009 from UNITED STATES Additional patient health information: Female patient , 87 years of age, was diagnosed with dementia alzheimer's type and. Namenda dosage: .

6874995-0 | Dermatitis Allergic
Adverse event was reported on Aug 25, 2009 by a Female patient taking Namenda (View Usage) (Dosage: See Image) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , 76 years of age, weighting 113.0 lb, Patient had the following side effects: dermatitis allergic. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), ACTONEL (View Actonel Review and Actonel Label ), RAZADYNE (View Razadyne Review and Razadyne Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6874992-5 | Aphasia, Emotional Distress, Fall, Gastrointestinal Disorder, Hip Fracture, Lethargy
on May 15, 2009 Female patient from UNITED STATES , 92 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: aphasia (What is aphasia?), emotional distress, fall (What is fall?), gastrointestinal disorder, hip fracture, lethargy. Namenda dosage: 5 Mg (5 Mg,1 In 1 D),oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CALTRATE (View Caltrate Review and Caltrate Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized.

6874987-1 | Blood Pressure Increased
on Apr 07, 2009 Female patient from UNITED STATES , 81 years of age, was diagnosed with dementia alzheimer's type, arthralgia and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased. Namenda dosage: 5 Mg (5 Mg,1 In 1 D),oral ; 10 Mg (5 Mg,2 In 1 D),oral ; 15 Mg, Oral. During the same period patient was treated with MELOXICAM (View Meloxicam Review and Meloxicam Label ), ARICEPT (View Aricept Review and Aricept Label ), EYE DROPS (NOS) (View Eye Drops (nos) Review and Eye Drops (nos) Label ).

6874979-2 | Pain, Suicidal Ideation, Thinking Abnormal
Patient was taking Namenda (View Usage). Patient had the following side effects: pain (What is pain?), suicidal ideation, thinking abnormal on Feb 18, 2009 from UNITED STATES Additional patient health information: Male patient , 42 years of age, was diagnosed with memory impairment and. Namenda dosage: See Image. During the same period patient was treated with CYMBALTA (30 MILLIGRAM, TABLETS) (View Cymbalta (30 Milligram, Tablets) Review and Cymbalta (30 Milligram, Tablets) Label ), ULTRAM (50 MILLIGRAM, TABLETS) (View Ultram (50 Milligram, Tablets) Review and Ultram (50 Milligram, Tablets) Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), FLEXERIL (10 MILLIGRAM, TABLETS) (View Flexeril (10 Milligram, Tablets) Review and Flexeril (10 Milligram, Tablets) Label ), VALIUM (5 MILLGRAM, TABLETS) (View Valium (5 Millgram, Tablets) Review and Valium (5 Millgram, Tablets) Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6874972-X | Decreased Appetite, Dizziness, Dyskinesia, Restless Legs Syndrome, Tremor, Weight Decreased
Adverse event was reported on May 06, 2009 by a Female patient taking Namenda (View Usage) (Dosage: 5 Mg (5 Mg,1 In 1 D),oral ; 10 Mg (5 Mg,2 In 1 D),oral ; 15 Mg,oral) was diagnosed with dementia (What is dementia?) and. Location: UNITED STATES , 86 years of age, weighting 102.0 lb, After Namenda was administered, patient had the following side effects: decreased appetite, dizziness (What is dizziness?), dyskinesia, restless legs syndrome, tremor, weight decreased. During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DIURETIC (NOS) (View Diuretic (nos) Review and Diuretic (nos) Label ). Patient was hospitalized.

6874970-6 | Grand Mal Convulsion
on Jun 02, 2009 Male patient from UNITED STATES , child 11 years of age, was diagnosed with autism (What is autism?) and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion. Namenda dosage: 5 Mg (5 Mg,1 In 1 D),oral. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ).

6874968-8 | Cerebrovascular Accident
on Mar 10, 2009 Male patient from UNITED STATES , 76 years of age, weighting 220.0 lb, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient had the following side effects: cerebrovascular accident. Namenda dosage: 5 Mg (5 Mg,1 In 1 D),oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), IMDUR (View Imdur Review and Imdur Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), AVAPRO (View Avapro Review and Avapro Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ). Patient was hospitalized.

6874966-4 | Confusional State, Depression, Suicidal Ideation
Patient was taking Namenda (View Usage). After Namenda was administered, patient had the following side effects: confusional state, depression (What is depression?), suicidal ideation on Nov 03, 2008 from UNITED STATES Additional patient health information: Male patient , 82 years of age, was diagnosed with amnesia and. Namenda dosage: 5 Mg (5 Mg,1 In 1 D),oral. During the same period patient was treated with ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), PLAVIX (View Plavix Review and Plavix Label ), PROPAFENONE (View Propafenone Review and Propafenone Label ), IRON (View Iron Review and Iron Label ).

6874964-0 | Suicidal Ideation
Adverse event was reported on Nov 04, 2008 by a Female patient taking Namenda (View Usage) (Dosage: 5 Mg (1 In 1 D),oral ; 10 Mg (5 Mg,2 In 1 D),oral) was diagnosed with migraine (What is migraine?) and. Location: UNITED STATES , 63 years of age, Patient experienced the following unwanted or unexpected effects: suicidal ideation. During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ), IMITREX (View Imitrex Review and Imitrex Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), CAFERGOT (View Cafergot Review and Cafergot Label ).

6874962-7 | Fall, Muscle Twitching, Tremor, Wrist Fracture
on Oct 02, 2009 Female patient from UNITED STATES , 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient had the following side effects: fall (What is fall?), muscle twitching, tremor, wrist fracture. Namenda dosage: 20 Mg (10 Mg,2 In 1 D),oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

6874958-5 | Hyponatraemia
on Aug 28, 2009 Male patient from UNITED STATES , 85 years of age, was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: hyponatraemia. Namenda dosage: 10 (10 ,1 In 1 D),oral. Patient was hospitalized.

6874955-X | Asthenia, Dizziness, Urinary Tract Infection
Patient was taking Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dizziness (What is dizziness?), urinary tract infection (What is urinary tract infection?) on Aug 05, 2009 from UNITED STATES Additional patient health information: Female patient , 77 years of age, was diagnosed with dementia alzheimer's type and. Namenda dosage: Oral. During the same period patient was treated with DETROL LA (View Detrol La Review and Detrol La Label ), EXELON (View Exelon Review and Exelon Label ), ACTONEL (View Actonel Review and Actonel Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), SUPPLEMENT (NOS) (View Supplement (nos) Review and Supplement (nos) Label ). Patient was hospitalized.

6874953-6 | Asthenia, Balance Disorder, Constipation, Diarrhoea, Dizziness, Fall
Adverse event was reported on Aug 04, 2009 by a Female patient taking Namenda (View Usage) (Dosage: See Image) was diagnosed with amnesia and. Location: UNITED STATES , 90 years of age, Patient had the following side effects: asthenia, balance disorder, constipation (What is constipation?), diarrhoea, dizziness (What is dizziness?), fall (What is fall?). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), IRON (View Iron Review and Iron Label ), ZOCOR (View Zocor Review and Zocor Label ), ZESTRIL (View Zestril Review and Zestril Label ). Patient was hospitalized.

6874791-4 | Hydrocephalus, Somnolence
on Jul 14, 2010 Male patient from UNITED STATES , 81 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: hydrocephalus (What is hydrocephalus?), somnolence. Namenda dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), KLOR CON (View Klor-con Review and Klor-con Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), QVAR 40 (View Qvar 40 Review and Qvar 40 Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6847541-5 | Drooling, Dysarthria, Hypoacusis, Tremor
on Jul 08, 2010 Male patient from UNITED STATES , 85 years of age, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: drooling, dysarthria, hypoacusis, tremor. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D), Oral. During the same period patient was treated with GABAPENTIN (300 MILLIGRAM, CAPSULES) (View Gabapentin (300 Milligram, Capsules) Review and Gabapentin (300 Milligram, Capsules) Label ), GALANTAMINE (View Galantamine Review and Galantamine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

6836579-X | Bone Marrow Disorder, Eye Swelling
Patient was taking Namenda (View Usage). Patient had the following side effects: bone marrow disorder, eye swelling on Jun 29, 2010 from UNITED STATES Additional patient health information: Female patient , 85 years of age, . Namenda dosage: . During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ).

6828518-2 | Abnormal Behaviour, Constipation, Decreased Eye Contact, Diarrhoea, Disturbance In Attention, Migraine
Adverse event was reported on Jul 08, 2010 by a Male patient taking Namenda (View Usage) (Dosage: 10 Mg Daily Po) was diagnosed with abnormal behaviour and. Location: UNITED STATES , child 7 years of age, weighting 91.00 lb, After Namenda was administered, patient had the following side effects: abnormal behaviour, constipation (What is constipation?), decreased eye contact, diarrhoea, disturbance in attention, migraine (What is migraine?).

6774176-5 | Diarrhoea, Dyskinesia, Headache, Nervousness
on Jun 16, 2010 Male patient from UNITED STATES , weighting 150.0 lb, was diagnosed with dementia (What is dementia?), dementia alzheimer's type and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, dyskinesia, headache (What is headache?), nervousness. Namenda dosage: 1 Tablet Daily.

6738547-5 | Small Intestinal Obstruction, Urinary Tract Infection
on May 13, 2010 Female patient from UNITED STATES , 82 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient had the following side effects: small intestinal obstruction, urinary tract infection (What is urinary tract infection?). Namenda dosage: 10 Mg (5 Mg, 2 In 1 D ), Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6725651-0 | Amnesia, Condition Aggravated, Disorientation, Memory Impairment
Patient was taking Namenda (View Usage). After Namenda was administered, patient had the following side effects: amnesia, condition aggravated, disorientation, memory impairment on May 13, 2010 from UNITED STATES Additional patient health information: Male patient , 85 years of age, weighting 160.0 lb, was diagnosed with memory impairment and. Namenda dosage: 10 Mg 1 X A Day.

6699843-3 | Deafness Unilateral, Hypoacusis, Off Label Use
Adverse event was reported on Apr 27, 2010 by a Male patient taking Namenda (View Usage) (Dosage: 5 Mg 1 X Day) was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and. Location: UNITED STATES , weighting 160.0 lb, Patient experienced the following unwanted or unexpected effects: deafness unilateral, hypoacusis, off label use.

6699475-7 | Asthenia, Blood Magnesium Decreased, Blood Potassium Decreased, Blood Sodium Decreased, Pulmonary Oedema, Renal Impairment, Urinary Retention
on Apr 15, 2010 Female patient from UNITED STATES , 88 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient had the following side effects: asthenia, blood magnesium decreased, blood potassium decreased, blood sodium decreased, pulmonary oedema, renal impairment, urinary retention. Namenda dosage: 20 Mg (10 Mg, 2 In 1 D), Oral. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PLAVIX (View Plavix Review and Plavix Label ), ARICEPT (View Aricept Review and Aricept Label ), WATER PILL (NOS)(TABLETS) (View Water Pill (nos)(tablets) Review and Water Pill (nos)(tablets) Label ). Patient was hospitalized.

6676356-6 | Blood Pressure Increased, Hallucination, Visual, Syncope
on Apr 02, 2010 Female patient from UNITED STATES , 92 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: blood pressure increased, hallucination, visual, syncope. Namenda dosage: Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6667301-8 | Aggression, Anxiety, Arrhythmia, Insomnia, Mood Altered, Paranoia
Patient was taking Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, anxiety (What is anxiety?), arrhythmia (What is arrhythmia?), insomnia, mood altered, paranoia on Mar 23, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with dementia (What is dementia?) and. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D), Oral, Oral, 20 Mg (10 Mg, 2 In 1 D), Oral). During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), RYTHMOL SR (View Rythmol Sr Review and Rythmol Sr Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), LORTAB (View Lortab Review and Lortab Label ), NICOTROL (View Nicotrol Review and Nicotrol Label ), ABILIFY (View Abilify Review and Abilify Label ). Patient was hospitalized.

6660365-7 | Chest Pain, Crying, Depressed Mood, Dyspnoea, Headache, Memory Impairment
Adverse event was reported on Mar 30, 2010 by a Female patient taking Namenda (View Usage) (Dosage: ) . Location: UNITED STATES , 77 years of age, weighting 140.0 lb, Patient had the following side effects: chest pain (What is chest pain?), crying, depressed mood, dyspnoea, headache (What is headache?), memory impairment.

6632986-9 | Angioedema
on Mar 02, 2010 Female patient from UNITED STATES , 86 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: angioedema. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D), Oral; 10 Mg (5 Mg, 2 In 1 D), Oral; 15 Mg (15 Mg, 1 In 1 D), Oral. During the same period patient was treated with VIAGRA (View Viagra Review and Viagra Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ). Patient was hospitalized.

6614623-2 | Angioedema
on Feb 22, 2010 Female patient from UNITED STATES , 86 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D),oral; 10 Mg (5 Mg, 2 In 1 D),oral; 15 Mg (15 Mg, 1 In 1 D),oral. During the same period patient was treated with VIAGRA (View Viagra Review and Viagra Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ). Patient was hospitalized.

6609256-8 | Dehydration, Dermatitis, Mental Status Changes
Patient was taking Namenda (View Usage). Patient had the following side effects: dehydration, dermatitis, mental status changes on Feb 18, 2010 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with dementia (What is dementia?) and. Namenda dosage: 15 Mg Daily, Oral. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), ARICEPT (View Aricept Review and Aricept Label ), PRILOSEC OTC (View Prilosec Otc Review and Prilosec Otc Label ), LASIX (View Lasix Review and Lasix Label ), TRICOR (View Tricor Review and Tricor Label ). Patient was hospitalized.